Rosenberg Matthew Hamilton

Position in OGN — Organon & Co.

CIK 1812103 GRAND JUNCTION, CO

Position in OGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$230

+$230 QoQ

Shares Held

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#563

of 626 holders

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Rosenberg Matthew Hamilton holds $5,886,852 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	4,135	$1,040,531
2	JNJ	Johnson & Johnson	3,924	$996,578
3	LLY	ELI LILLY & Co	748	$897,173
4	MRK	Merck & Co., Inc.	5,672	$728,852
5	AMGN	Amgen Inc	1,419	$513,848
6	GILD	Gilead Sciences, Inc.	3,450	$435,873
7	AZN	Astrazeneca PLC	2,051	$388,910
8	NVO	Novo Nordisk A S	5,989	$287,112

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$230	17	—	Shares	Sole	2026-07-17
2024-12-31	$0	0	-100.0%	Shares	Sole	2025-01-14
2024-09-30	$3,099	162	0.0%	Shares	Sole	2024-10-28
2024-06-30	$3,353	162	-1.8%	Shares	Sole	2024-07-26
2024-03-31	$3,102	165	+685.7%	Shares	Sole	2024-04-22
2023-12-31	$302	21	-65.0%	Shares	Sole	2024-01-16
2023-09-30	$1,041	60	-73.1%	Shares	Sole	2023-10-11
2023-06-30	$4,640	223	-53.2%	Shares	Sole	2023-07-26
2023-03-31	$11,195	476	0.0%	Shares	Sole	2023-04-17
2022-12-31	$13,294	476	+0.2%	Shares	Sole	2023-01-19
2022-09-30	$11,115	475	+452.3%	Shares	Sole	2022-10-21
2022-06-30	$2,902	86	+3.6%	Shares	Sole	2022-07-15
2021-12-31	$2,527	83	0.0%	Shares	Sole	2022-01-20
2021-09-30	$2,721	83	—	Shares	Sole	2021-10-12
No filing history on record for this holder in this stock.